var path='https://www.tickertech.net'; function heading(heading) { document.write('

'+ ''+ '
• '+heading+'
'+ ''+ '

'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('
•\; Detailed Quotes - AZNSaturday, May 4, 6:26 AM\n'); } if (allow) { document.write('

\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('
Look under \'\'More Info\'\' for further information. At least 20 min. delay.  \;
\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write(' \n'); } if (allow) { document.write(' \n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write(' Astrazeneca Plc - American Depositary SH (NASD: AZN)\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('More Info: \n'); } if (allow) { document.write('chart  \;comp profile  \;stock screen  \;news  \;www.astrazeneca.com \n'); } if (allow) { document.write(' ValueForum rating\n'); } if (allow) { document.write(' \n'); } if (allow) { document.write('\n'); } if (allow) { document.write('
Last Trade
4:00 p.m. - 76.37
Change
 \;0.57 ( \;0.75%)
Trades Today
66,219
Day\'s Volume
9,026,349
Beta
0.5523
Day\'s Range
75.43 - 76.49
Prev Close
75.80
Open
76.47
52 Wk Range
60.47 - 76.80
EPS
1.905
PE
37.71
Semi-annual Div/Shr
0.985
Ex-Div
02/22/24
Yield
2.58%
Shares Out.
3.10B
Market Cap.
236.78B
\n'); } if (allow) { document.write(' \; \;•\; \;1 Year Stock Performance: \; \; \;\n'); } if (allow) { document.write('
\n'); } var SC_width= "549"; var SC_height= "274"; var SC_clientId = "etfchannel"; var SC_type= "line"; var SC_period = "1y"; var SC_chartBackgroundColor= "FFFFFF"; var SC_gridLocation= "background"; var SC_labelSide = "left"; var SC_gridBackgroundColor= "F6F6F6"; var SC_gridColor= "CCCCCC"; var SC_axisColor= "222222"; var SC_symbols= "AZN"; var SC_showHighsLows= "no"; var SC_movingAverages= "no"; var SC_movingAverageColors = "FF8800,009900"; var SC_symbolLabels= "yes"; var SC_lineThicknesses= "1"; var SC_lineColors= "222222,AD0000,00FF00,DE6E00,ACA715,3C86AC,AC009A,FF0000,07AD80,1400AC"; var SC_showPrevClose= "no"; var SC_prevCloseColor= "600000"; var SC_fillBelowLine = "yes"; var SC_fillColor= "89D48C"; var SC_fillColor2= "89D48C"; var SC_smoothChart= "yes"; var SC_smoothFonts= "yes"; var SC_fontFace= "Arial"; var SC_fontSize= "2"; var SC_labelColor= "222222"; var SC_bottomLabels= ""; var SC_beforeLeftLabels= escape(''); var SC_afterLeftLabels= escape(''); var SC_leftLabelsEvery= "12"; var SC_leftBuffer= "35"; var SC_rightBuffer= "55"; var SC_bottomBuffer= "25"; var SC_bottomTableHeight= "30"; var SC_showVolumeTable= "yes"; var SC_showLegendTable = "no"; var SC_volumeColor= "222222"; document.write('Loading chart © 2001 TickerTech.com'); if (allow) { document.write('
\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('1 Quarter \; \;| \; \;1 Year \;\n'); } if (allow) { document.write('| \;\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('5 Years \; \;|\n'); } if (allow) { document.write(' \;Compare multiple stocks: \;\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('
Enter symbols: \;
\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write(' \n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('
 \;symbol lookup \; \; Find more stocks like \;
\n'); } heading('Related News'); if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('
5/2 - 7:00 AM \; \;CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial
5/1 - 7:05 AM \; \;AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio
4/29 - 7:00 AM \; \;ENHERTU (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow
4/29 - 2:00 AM \; \;ENHERTU Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial
4/25 - 10:58 AM \; \;Nasdaq 100 Movers: META, AZN [VIDEO]
4/25 - 8:06 AM \; \;AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
4/25 - 2:00 AM \; \;Q1 2024 results
4/16 - 8:00 AM \; \;Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
4/16 - 7:00 AM \; \;IMFINZI (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial
4/11 - 7:00 AM \; \;FASENRA approved for treatment of children aged 6 to 11 with severe asthma
4/5 - 11:10 PM \; \;ENHERTU Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors
4/5 - 9:43 PM \; \;ENHERTU (fam-trastuzumab deruxtecan-nxki) approved in the US as first tumor-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumors
4/5 - 7:00 AM \; \;IMFINZI (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial
4/2 - 7:00 AM \; \;Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer
4/2 - 2:00 AM \; \;Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
more news\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('Enter search terms: \;\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('

\n'); } if (allow) { document.write(' \n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write('\n'); } if (allow) { document.write(' \n'); } if (allow) { document.write(' \n'); } if (allow) { document.write(' \n'); } if (allow) { document.write(' \n'); } if (allow) { document.write('
TickerTech.com\n'); } if (allow) { document.write(' \n'); } if (allow) { document.write(' Private-label branded pages powered by TickerTech.com. \n'); } if (allow) { document.write(' Copyright ©\; 2024 Ticker Technologies, \n'); } if (allow) { document.write('All Rights Reserved. Quote data is at least 20 minutes delayed. \n'); } if (allow) { document.write('NYMEX data is at least 30 minutes delayed. Please read other important \n'); } if (allow) { document.write(' disclaimer information.\n'); } if (allow) { document.write('
\n'); } if (!allow) { document.write(''+ ''+ '

Access Denied

'+ '

Please Read This Important Message

'+ ' If you are a paying TickerTech.com client and your account was not set up to include the configuration'+ ' received, please email support@tickertech.com,'+ ' or call us at 1-866-515-2082 to verify your account settings.'+ ' '+ '

'+ ' '+ ' Note! If you reached this page'+ ' after attempting to place a TickerTech.com product onto your web page, go no further; you must sign up as a'+ ' paying client. For pricing information please visit our products page, email '+ ' services@tickertech.com, or give us a call at 1-866-515-2082.'+ ' '+ '

'+ ' '+ ' TickerTech.com home
'+ ' TickerTech.com products'+ '
'+ ' '+ ''); } }